Boo Pharmaceuticals-B (02142.HK) plans to offer a discount of approximately 9.45% for the rights issue, with a net amount raised of about 5.117 billion Hong Kong dollars.

The Zhongtong Financial News App reported that Hepio Pharmaceuticals-B (02142.HK) announced on August 29, 2025, that the company had entered into a placement agreement with the placing agent. Under this agreement, the company conditionally agreed to place a total of 45.022 million shares through the placing agent to no fewer than six placees at a price of HK$11.50 per share. The price of HK$11.50 per share represents a discount of approximately 9.45% compared to the closing price of HK$12.70 per share on August 28, 2025.